Latest News
17-Apr-2025 A Shot in the Arm for Local Pharma
17-Apr-2025 Regulator Bans 35 Combination Drugs over Safety Issues
15-Apr-2025 Sweet Surrender: Sanofi Puts Star Insulin Brand on Block
15-Apr-2025 US Tariff on China may Hurt Indian Pharma
11-Apr-2025 Global Tariff Risks Cloud Near-Term Pharma Outlook: Rothschild’s Beschi
  more...
Latest Reports
Apr-25 HSIE Research is also available on Bloomberg ERH HDF & Thomson Reuters Pharma dodges first round of US tariff risk - HDFC Securities  
Jan-25 March of corporate hospitals: Deepening presence - Emkay Research  
Jan-25 US pricing pressure eases; margins improve - Nirmal Bang  
Jan-25 Chemicals/Pharma EXIM trends - Phillip Capital  
Jan-25 3QFY25 Preview: Change in script unlikely - Emkay Research  
  more...

Quarterly Summary September-2024
Desc Current Previous Per.Chg
Sales 67242.7 61013.1 10.2
Otherincome 2488.6 2287.7 8.8
Expense 49904.7 47193.7 5.7
RawMaterial 19003.4 18996.8 0.0
StaffCost 9916.5 9105.9 8.9
ExciseDuty 78.8 58.9 33.9
OtherExp 15371.3 14258.0 7.8
Interest 1058.2 1028.8 2.9
GrossProfit 20070.8 16023.1 25.3
Depreciation 2672.0 2717.1 -1.7
Tax 4076.5 2892.1 41.0
NetProfit 13339.3 10504.1 27.0
Total.Comp 176 -- --
Source: ETIG Database

Sectoral Companies As on 16 Apr 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 406117.51
Divi's Lab 152832.84
Cipla 120857.34
Torrent Phar 109018.29
Mankind Phar 104076.29
Dr.Reddy's 96760.28
Lupin 88378.95
Zydus Life 82719.70
Aurobindo Ph 66370.75
Abbott (I) 65271.08
Alkem Labora 59254.96
GlaxoSmith.P 49613.41
Glenmark Pha 38293.13
  click here for the complete list